Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2010

May 18, 2010

30198_dirs_2010-05-18_e1a3c339-24fe-4912-b0e1-ee605a8f3baa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-05-14

Reporting Person: LORD JONATHAN T MD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-05-14 Common Stock P 300 $10.69 Acquired 5411 Direct
2010-05-14 Common Stock P 1300 $10.695 Acquired 6711 Direct
2010-05-14 Common Stock P 100 $10.723 Acquired 6811 Direct
2010-05-14 Common Stock P 4000 $10.73 Acquired 10811 Direct
2010-05-14 Common Stock P 300 $10.735 Acquired 11111 Direct
2010-05-14 Common Stock P 300 $10.738 Acquired 11411 Direct
2010-05-14 Common Stock P 400 $10.74 Acquired 11811 Direct
2010-05-14 Common Stock P 100 $10.745 Acquired 11911 Direct
2010-05-14 Common Stock P 200 $10.748 Acquired 12111 Direct
2010-05-14 Common Stock P 12920 $10.75 Acquired 25031 Direct
2010-05-14 Common Stock P 100 $10.76 Acquired 25131 Direct
2010-05-14 Common Stock P 100 $10.77 Acquired 25231 Direct
2010-05-14 Common Stock P 700 $10.78 Acquired 25931 Direct
2010-05-14 Common Stock P 100 $10.79 Acquired 26031 Direct
2010-05-14 Common Stock P 9002 $10.8 Acquired 35033 Direct
2010-05-14 Common Stock P 300 $10.84 Acquired 35333 Direct
2010-05-14 Common Stock P 9897 $10.85 Acquired 45230 Direct